cilostazol has been researched along with Thromboembolism in 6 studies
Thromboembolism: Obstruction of a blood vessel (embolism) by a blood clot (THROMBUS) in the blood stream.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Among the key recommendations in this chapter are the following: For patients with chronic limb ischemia, we recommend lifelong aspirin therapy in comparison to no antiplatelet therapy in patients with clinically manifest coronary or cerebrovascular disease (Grade 1A) and in those without clinically manifest coronary or cerebrovascular disease (Grade 1C+)." | 4.82 | Antithrombotic therapy in peripheral arterial occlusive disease: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. ( Clagett, GP; Jackson, MR; Lip, GY; Sobel, M; Tangelder, M; Verhaeghe, R, 2004) |
| "Replacement of thienopyridine with aspirin or cilostazol may be acceptable for minimizing both the risk of post-ESD bleeding and thromboembolism in patients with EGC." | 4.31 | Association between perioperative management of antiplatelet agents and risk of post-endoscopic submucosal dissection bleeding in early gastric cancer: analysis of a nationwide multicenter study. ( Asahina, Y; Fujishiro, M; Hasatani, K; Hatta, W; Hayashi, Y; Hikichi, T; Hoteya, S; Iguchi, M; Inoue, T; Kikuchi, D; Kiyotoki, S; Kobayashi, M; Kuribayashi, S; Mabe, K; Masamune, A; Matsumura, T; Michida, T; Mikami, T; Miura, Y; Morita, Y; Nagami, Y; Nakamatsu, D; Narasaka, T; Nebiki, H; Nishikawa, J; Ohnita, K; Sugimoto, M; Sumiyoshi, T; Suzuki, H; Tomida, H; Tsuji, S; Tsuji, Y; Ueyama, H; Yabuuchi, Y; Yada, T; Yamaguchi, S; Yoshio, T, 2023) |
| "To clarify the frequency of Japanese patients who are resistant to antiplatelet agents, and then clarify correlations between resistance and thromboembolic adverse events in neurointervention." | 1.38 | [Resistance to antiplatelet agents assessed by a point-of-care platelet function test and thromboembolic adverse events in neurointervention]. ( Asai, T; Haraguchi, K; Izumi, T; Matsubara, N; Miyachi, S; Naito, T; Wakabayashi, T; Yamanouchi, T, 2012) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 4 (66.67) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Miura, Y | 1 |
| Tsuji, Y | 1 |
| Yoshio, T | 1 |
| Hatta, W | 1 |
| Yabuuchi, Y | 1 |
| Hoteya, S | 1 |
| Kikuchi, D | 1 |
| Tsuji, S | 1 |
| Nagami, Y | 1 |
| Hikichi, T | 1 |
| Kobayashi, M | 1 |
| Morita, Y | 1 |
| Sumiyoshi, T | 1 |
| Iguchi, M | 1 |
| Tomida, H | 1 |
| Inoue, T | 1 |
| Mikami, T | 1 |
| Hasatani, K | 1 |
| Nishikawa, J | 1 |
| Matsumura, T | 1 |
| Nebiki, H | 1 |
| Nakamatsu, D | 1 |
| Ohnita, K | 1 |
| Suzuki, H | 1 |
| Ueyama, H | 1 |
| Hayashi, Y | 1 |
| Sugimoto, M | 1 |
| Yamaguchi, S | 1 |
| Michida, T | 1 |
| Yada, T | 1 |
| Asahina, Y | 1 |
| Narasaka, T | 1 |
| Kuribayashi, S | 1 |
| Kiyotoki, S | 1 |
| Mabe, K | 1 |
| Masamune, A | 1 |
| Fujishiro, M | 1 |
| Panchal, HB | 1 |
| Shah, T | 1 |
| Patel, P | 1 |
| Albalbissi, K | 1 |
| Molnar, J | 1 |
| Coffey, B | 1 |
| Khosla, S | 1 |
| Ramu, V | 1 |
| Park, KH | 1 |
| Jeong, MH | 1 |
| Lee, KH | 1 |
| Sim, DS | 1 |
| Yoon, HJ | 1 |
| Yoon, NS | 1 |
| Kim, KH | 1 |
| Park, HW | 1 |
| Hong, YJ | 1 |
| Kim, JH | 1 |
| Ahn, Y | 1 |
| Cho, JG | 1 |
| Park, JC | 1 |
| Kang, JC | 1 |
| Ueda, H | 1 |
| Kido, A | 1 |
| Matsuhisa, S | 1 |
| Asawa, K | 1 |
| Yoshida, N | 1 |
| Tsujimoto, M | 1 |
| Sasaki, Y | 1 |
| Kuga, Y | 1 |
| Yamasaki, M | 1 |
| Ueda, K | 1 |
| Shinohara, S | 1 |
| Nishida, Y | 1 |
| Haraguchi, K | 1 |
| Miyachi, S | 1 |
| Izumi, T | 1 |
| Matsubara, N | 1 |
| Naito, T | 1 |
| Asai, T | 1 |
| Yamanouchi, T | 1 |
| Wakabayashi, T | 1 |
| Clagett, GP | 1 |
| Sobel, M | 1 |
| Jackson, MR | 1 |
| Lip, GY | 1 |
| Tangelder, M | 1 |
| Verhaeghe, R | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Comparison of Dual-Antiplatelet and Triple-Antiplatelet Preparation Using P2Y12 Assay in Patients With High On-Treatment Platelet Reactivity Undergoing Stent-Assisted Coil Embolization for An Unruptured Intracranial Aneurysm[NCT03581409] | Phase 4 | 198 participants (Actual) | Interventional | 2018-10-24 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 reviews available for cilostazol and Thromboembolism
| Article | Year |
|---|---|
Comparison of on-treatment platelet reactivity between triple antiplatelet therapy with cilostazol and standard dual antiplatelet therapy in patients undergoing coronary interventions: a meta-analysis.
Topics: Aspirin; Blood Platelets; Cilostazol; Clopidogrel; Coronary Artery Disease; Drug Therapy, Combinatio | 2013 |
Antithrombotic therapy in peripheral arterial occlusive disease: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.
Topics: Arterial Occlusive Diseases; Aspirin; Cilostazol; Clopidogrel; Contraindications; Evidence-Based Med | 2004 |
2 trials available for cilostazol and Thromboembolism
| Article | Year |
|---|---|
Comparison of peri-procedural platelet inhibition with prasugrel versus adjunctive cilostazol to dual anti-platelet therapy in patients with ST segment elevation myocardial infarction.
Topics: Aged; Cilostazol; Electrocardiography; Female; Humans; Male; Middle Aged; Myocardial Infarction; Per | 2014 |
Addition of cilostazol to aspirin therapy for secondary prevention of cardiovascular and cerebrovascular disease in patients undergoing percutaneous coronary intervention: A randomized, open-label trial.
Topics: Aged; Aspirin; Cerebrovascular Disorders; Cilostazol; Dose-Response Relationship, Drug; Drug Therapy | 2016 |
2 other studies available for cilostazol and Thromboembolism
| Article | Year |
|---|---|
Association between perioperative management of antiplatelet agents and risk of post-endoscopic submucosal dissection bleeding in early gastric cancer: analysis of a nationwide multicenter study.
Topics: Aspirin; Cilostazol; Endoscopic Mucosal Resection; Gastric Mucosa; Gastrointestinal Hemorrhage; Gast | 2023 |
[Resistance to antiplatelet agents assessed by a point-of-care platelet function test and thromboembolic adverse events in neurointervention].
Topics: Adult; Aged; Aspirin; Cilostazol; Clopidogrel; Drug Resistance; Female; Humans; Intracranial Aneurys | 2012 |